DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Purinergic signalling
Purinergic signalling
Purinergic Signalling in Skin
P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases
Hypoxia Modulates Platelet Purinergic Signalling Pathways
Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?
Caffeine Has a Dual Influence on NMDA Receptor–Mediated Glutamatergic Transmission at the Hippocampus
Regulation of Microglial Functions by Purinergic Mechanisms in the Healthy and Diseased CNS
Purinergic Receptors Brian F
Special Issue for Purinergic Receptors, Particularly P2X7 Receptor, in the Eye
Purinergic Signalling in Neurodegeneration, Neuroprotection and Neuroregeneration
Purinergic Signalling in the CNS Geoffrey Burnstock*
Purinergic Regulation of Vascular Tone and Remodelling
Role of Adenosine and Purinergic Receptors in Myocardial Infarction: Focus on Different Signal Transduction Pathways
Role of Purinergic Signalling and Proinflammatory Cytokines in Diabetes
The Roles of Purinergic Signaling in Psychiatric Disorders Marek Cieślak1, Joanna Czarnecka2* and Katarzyna Roszek2
P2 Receptors in Cardiac Myocyte Pathophysiology and Mechanotransduction
Antithrombotic P2Y12 Receptor Antagonists: Recent Developments in Drug Discovery
Purinergic Receptors and Gastrointestinal Secretomotor Function
Purinergic Signaling and Related Biomarkers in Depression
Top View
The Role of Purinergic Signalling in Inflammatory Disorders
Therapeutic Developments
Purinergic Receptors of the Central Nervous
Purinergic Signalling and Neurological Diseases: an Update
Purinergic P2X7 Receptors and Chronic Kidney Disease
Purinergic Receptors: Elucidating the Role of These Immune Mediators in HIV-1 Fusion
Disturbances of Purinergic System in Affective Disorders and Schizophrenia
Inhibitory Effects of ATP and Adenosine on Cholangiocarcinoma Cell Proliferation and Motility JOMNARONG LERTSUWAN 1 and MATHUROS RUCHIRAWAT 2
Activation of P2X7 and P2Y11 Purinergic Receptors Inhibits
REVIEW Purinergic Signalling in the Pancreas in Health and Disease
Purinergic Signalling Pathway: Therapeutic Target in Ovarian Cancer
The Involvement of Purinergic Signalling in Obesity
1 Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
Purinergic Signalling in Parkinson's Disease: a Multi-Target System To
Purinergic Signaling in the Pathophysiology and Treatment of Huntington’S Disease
Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A3 Receptor Subtype
Neuroprotection by Adenosine in the Brain: from A1 Receptor Activation to A2A Receptor Blockade
P2X7 Receptor at the Crossroads of T Cell Fate
Potential Therapeutic Targets in the Rapidly Expanding Field of Purinergic Signalling
Role of Purinergic Signalling in Endothelial Dysfunction and Thrombo-Inflammation in Ischaemic Stroke and Cerebral Small Vessel Disease
Adenosine and Inflammation
Constitutive P2Y2 Receptor Activity Regulates Basal Lipolysis in Human Adipocytes Seema B
Purinergic Neurotransmission (PDF)
Purinergic Signalling. British Journal of Pharmacology